BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 23, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

GCS-100: Completed Phase IIa enrollment

La Jolla completed enrollment of 121 patients with stage 3b or 4 CKD in a single-blind, placebo-controlled, U.S. Phase IIa trial evaluating 1.5...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >